Cardiomyopathy weakens, enlarges, or stiffens the heart muscle. Heart failure is when the heart is unable to pump enough blood around the body, resulting in symptoms. Cardiomyopathy is one of the ...
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized yet frequently underdiagnosed cause of heart ...
A sweeping international study has identified ways to detect patients who are at serious risk of sudden death, heart failure ...
BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, announced today upcoming presentations, ...
Finerenone use in trial patients with HFpEF or HFmrEF increased hyperkalemia risk, especially in those with CKD. Finerenone use in patients with heart failure and preserved or mildly reduced ejection ...
Findings from a new study have identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM), a heart ...
A patient fact sheet outlining the differences between heart failure and cardiomyopathy, including subtypes of each condition and diagnostic procedures for both. Cardiomyopathy is a group of heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results